Medical Health Insurance Florida Tampa, FL (Vocus) December 9, 2008 As medical health insurance costs in Florida and around the nation continue to rise, Allegiance Financial Services sees an interesting phenomenon taking place. Families of people whose medical insurance is provided as a benefit by their employers are beginning to drop [...]

Continue reading " Medical Health Insurance in Florida: Allegiance Financial Notes Many Finding Better Coverage by Leaving Their Employer Plans Behind "

China Pharmaceuticals, Inc. (OTC Bulletin Board: CFMI) (“China Pharmaceuticals Inc.” or the “Company”), one of China’s leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, announced record financial results for its second quarter ended June 30, 2010. The Company’s annual report on Form 10-Q was filed on August 23, 2010 with the United States Securities [...]

Continue reading " China Pharmaceuticals, Inc. (CFMI) Reports Record Q2 Results: Sales Grow 105% "

Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $121,719, the best ever quarter in terms of revenues in corporate history and an increase of 25% over the $97,424 recorded in the third quarter, fiscal year 2009. [...]

Continue reading " Bio-Reference Laboratories, Inc. Announces 25% Revenue Growth, 17% Patient Growth, Record Income "

Veritas Revenue Up 55 Percent Over Year-Ago Quarter; Peri-Strips Revenue Sets Quarterly Record; Record Microsurgery Revenue Up 13 Percent Synovis Life Technologies, Inc. (Nasdaq: SYNO), reported its financial results for the third quarter ended July 31, 2010. For the 2010 fiscal third quarter, net revenue rose to $17.6 million, a 17 percent increase over $15.0 [...]

Continue reading " Synovis Life Technologies Reports 17 Percent Year-Over-Year Revenue Growth for Fiscal 2010 Third Quarter "

BioAlliance Pharma SA (Paris:BIO)(Euronext Paris – BIO), a company dedicated to the supportive care and treatment of cancer patients, presented its consolidated half-year accounts to June 30, 2010. The first half of 2010 was marked by two major events that testify to the quality of BioAlliance Pharma’s teams and products: * European licensing agreement of [...]

Continue reading " BioAlliance Pharma SA: Consolidated Accounts for the First Semester of 2010 "

Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) provided preliminary, unaudited and unreviewed information on its financial performance for the first half of 2010. Taro continues to make significant operational and financial progress. * Sales for the first half of 2010 grew to approximately $187 million * Net income for the first half [...]

Continue reading " Taro Provides Preliminary First Half 2010 Financial Results "

California family health insurance provider. Orange, CA (PRWEB) September 11, 2008 A reliable team that can help with obtaining health insurance is a valuable resource; insurance at reduced rates can be even more welcome. Frontline Insurance and Financial Services provides both and is now offering 40% savings on family health insurance [...]

Continue reading " Frontline Insurance and Financial Services Announces 40 Percent Savings on Family Health Insurance Plans, California Area "

ImmunoCellular Therapeutics (OTCBB: IMUC) announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical [...]

Continue reading " ImmunoCellular Therapeutics Announces 2010 Second Quarter Results "

Cambridge Heart, Inc. (OTCBB: CAMH), reported results for the three and six months ended June 30, 2010. Full financial statements and corresponding commentary can be found in the Company’s Form 10-Q, which is expected to be filed with the Securities and Exchange Commission on August 16, 2010. The following financial and strategic milestones highlight the [...]

Continue reading " Cambridge Heart Reports Results for the Three and Six Months Ended June 30, 2010 "

A.P. Pharma, Inc. (NASDAQ: APPA), a specialty pharmaceutical company, reported financial results for its second quarter ended June 30, 2010. Operational Highlights In May, the Company engaged a leading regulatory consulting group to lead the U.S. Food and Drug Administration (FDA) review process and assist in preparing its resubmission of a New Drug Application (NDA) [...]

Continue reading " A.P. Pharma Announces Second Quarter 2010 Financial Results "